Achieving and maintaining an optimal trough level for prophylaxis in haemophilia: the past, the present and the future

被引:58
作者
Jimenez-Yuste, Victor [1 ]
Auerswald, Guenter [2 ]
Benson, Gary [3 ]
Lambert, Thierry [4 ,5 ]
Morfini, Massimo [6 ]
Remor, Eduardo [7 ]
Salek, Silva Zupancic [8 ]
机构
[1] La Paz Univ Hosp, Coagulopathy Unit, Haematol Serv, Madrid, Spain
[2] Prof Hess Childrens Hosp, Bremen Mitte Clin, Bremen, Germany
[3] Northern Ireland Haemophilia Comprehens Care Ctr, Belfast, Antrim, North Ireland
[4] Bicetre AP HP Hosp, Hemophilia Care Ctr, Paris, France
[5] Univ Paris 11, Fac Med, Paris, France
[6] Univ Hosp Careggi, Dept Emergency & Recept, Agcy Haemophilia, Reference Ctr Inherited Bleeding Disorders Tuscan, Florence, Italy
[7] Univ Autonoma Madrid, Fac Psychol, Dept Psychobiol & Hlth, Madrid 28046, Spain
[8] Univ Hosp Ctr Rebro, Dept Internal Med, Div Haematol, Natl Haemophilia & Thrombophilia Ctr, Zagreb, Croatia
关键词
arthropathy; haemophilia; prophylaxis; trough; RECOMBINANT FACTOR-IX; COAGULATION-FACTOR IX; FC FUSION PROTEIN; FACTOR-VIII; PHARMACOKINETIC PROPERTIES; PROLONGED ACTIVITY; JOINT DISEASE; RIX-FP; SAFETY; CHILDREN;
D O I
10.2450/2014.0298-13
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:314 / 319
页数:6
相关论文
共 31 条
[1]  
Ahlberg A., 1965, Acta Orthop Scand Suppl, P3, DOI DOI 10.3109/ORT.1965.36.SUPPL-77.01
[2]   Modern haemophilia care [J].
Berntorp, Erik ;
Shapiro, Amy D. .
LANCET, 2012, 379 (9824) :1447-1456
[3]   Association Between Physical Activity and Risk of Bleeding in Children With Hemophilia [J].
Broderick, Carolyn R. ;
Herbert, Robert D. ;
Latimer, Jane ;
Barnes, Chris ;
Curtin, Julie A. ;
Mathieu, Erin ;
Monagle, Paul ;
Brown, Simon A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (14) :1452-1459
[4]   Thromboelastography in children with coagulation factor deficiencies [J].
Chitlur, Meera ;
Warrier, Indira ;
Rajpurkar, Madhvi ;
Hollon, Wendy ;
Llanto, Lolita ;
Wiseman, Carol ;
Lusher, Jeanne M. .
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (02) :250-256
[5]   Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX [J].
Collins, P. W. ;
Moss, J. ;
Knobe, K. ;
Groth, A. ;
Colberg, T. ;
Watson, E. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (11) :2305-2312
[6]   Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A [J].
Collins, P. W. ;
Blanchette, V. S. ;
Fischer, K. ;
Bjorkman, S. ;
Oh, M. ;
Fritsch, S. ;
Schroth, P. ;
Spotts, G. ;
Astermark, J. ;
Ewenstein, B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (03) :413-420
[7]   Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: An international multicentre study [J].
Dargaud, Yesim ;
Wolberg, Alisa S. ;
Luddington, Roger ;
Regnault, Veronique ;
Spronk, Henri ;
Baglin, Trevor ;
Lecompte, Thomas ;
Ten Cate, Hugo ;
Negrier, Claude .
THROMBOSIS RESEARCH, 2012, 130 (06) :929-934
[8]   Clinical severity of haemophilia A: does the classification of the 1950s still stand? [J].
Den Uijl, I. E. M. ;
Bunschoten, E. P. Mauser ;
Roosendaal, G. ;
Schutgens, R. E. G. ;
Biesma, D. H. ;
Grobbee, D. E. ;
Fischer, K. .
HAEMOPHILIA, 2011, 17 (06) :849-853
[9]   Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels [J].
den Uijl, I. E. M. ;
Fischer, K. ;
van der Bom, J. G. ;
Grobbee, D. E. ;
Rosendaal, F. R. ;
Plug, I. .
HAEMOPHILIA, 2011, 17 (01) :41-44
[10]   A comparison of traditional vs. Canadian tailored prophylaxis dosing of prophylactic factor infusions in children with haemophilia A and B in a single hemophilia treatment center [J].
Dodd, C. ;
Watts, R. G. .
HAEMOPHILIA, 2012, 18 (04) :561-567